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ABSTRACT
Objective To assess the seasonality of cardiovascular
risk factors (CVRF) in a large set of population-based
studies.
Methods Cross-sectional data from 24 population-
based studies from 15 countries, with a total sample
size of 237 979 subjects. CVRFs included Body Mass
Index (BMI) and waist circumference; systolic (SBP) and
diastolic (DBP) blood pressure; total, high (HDL) and
low (LDL) density lipoprotein cholesterol; triglycerides
and glucose levels. Within each study, all data were
adjusted for age, gender and current smoking. For blood
pressure, lipids and glucose levels, further adjustments
on BMI and drug treatment were performed.
Results In the Northern and Southern Hemispheres,
CVRFs levels tended to be higher in winter and lower in
summer months. These patterns were observed for most
studies. In the Northern Hemisphere, the estimated
seasonal variations were 0.26 kg/m2 for BMI, 0.6 cm for
waist circumference, 2.9 mm Hg for SBP, 1.4 mm Hg for
DBP, 0.02 mmol/L for triglycerides, 0.10 mmol/L for total
cholesterol, 0.01 mmol/L for HDL cholesterol,
0.11 mmol/L for LDL cholesterol, and 0.07 mmol/L for
glycaemia. Similar results were obtained when the
analysis was restricted to studies collecting fasting blood
samples. Similar seasonal variations were found for most
CVRFs in the Southern Hemisphere, with the exception
of waist circumference, HDL, and LDL cholesterol.
Conclusions CVRFs show a seasonal pattern
characterised by higher levels in winter, and lower levels
in summer. This pattern could contribute to the
seasonality of CV mortality.
INTRODUCTION
Cardiovascular diseases (CVD) are the main cause
of death worldwide, accounting for almost 32% of
all deaths in women and 27% in men.1
Cardiovascular events have been shown to present
a seasonal pattern, their rates being higher in
winter than in other seasons.2 Several explanations
have been put forward, from misclassiﬁcation of
CVD deaths3 to changes in air temperature.4
A study conducted in 15 European cities showed
that a decrease in air temperature of 1°C could lead
to a 1.72% increase in the number of CVD
deaths.5 Seasonal patterns for cardiovascular risk
factors (CVRF) have also been suggested for Body
Mass Index (BMI),6 waist circumference,6 blood
pressure,7 lipids,8 and glycaemia.9 However, most
studies assessing the seasonality of CVRFs have
been conducted in relatively small studies or
focused on a single CVRF.
Thus, the aim of this study was to assess whether
CVRFs present a seasonal pattern, and if so, if this
pattern is reproducible between countries. We used
data from over 230 000 subjects from 24 studies
(Northern Hemisphere: 192 129, Southern
Hemisphere: 45 850) to achieve this aim.
METHODS
Studies included and data collection
Data from 24 population-based studies from 15
countries were included (Australia, Belgium, Czech
Republic, Denmark, France, Italy, Lithuania, New
Zealand, Northern Ireland, Norway, Portugal,
Principality of Liechtenstein, Russia, Spain and
Switzerland). The studies were initially gathered by
the Prevention, Epidemiology and Population
Science section of the European Association for
Cardiovascular Prevention and Rehabilitation
(EACPR), and other studies considered of interest
were then invited. Twenty-one studies were from the
Northern Hemisphere and three from the Southern
Hemisphere. Information for the following CVRFs
was collected: BMI; waist circumference; systolic
(SBP) and diastolic blood pressure (DBP); total, high
(HDL) and low (LDL) density lipoprotein choles-
terol; triglycerides (log-transformed values) and
blood glucose. Only data with the following criteria
were considered: adult (≥18 years) participants,
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objectively measured (non-self-reported) data, and data collection
at least during an entire year. Missing data for a single month was
not considered as an exclusion criterion for a study.
Each study provided monthly adjusted means and their asso-
ciated SEs for the CVRFs available. Within each study, BMI and
waist were adjusted for age (continuous), gender and current
smoking (yes/no). For blood pressure, lipids and glucose levels,
further adjustments on BMI and drug treatment (yes/no) were
performed. A description of the studies is provided in online
supplementary table S1.
Statistical analyses
Statistical analyses were performed using R Development Core
Team (2011).10 To assess seasonality of CVRFs, weighted
ﬁxed-effects models including cosinor were used for testing a
sinusoidal pattern, that is, a function assuming a cyclical and
symmetrical behaviour of CVRFs over time and over their esti-
mated mean.11 Due to the opposite seasons in both
Hemispheres, speciﬁc models according to Northern or
Southern Hemisphere were applied. For each hemisphere, a
joint model including the study indicator variable besides sine
and cosine functions was adjusted
CVRF ¼ b0 þ b1 sin
2pt
T
 
þ b2 cos
2pt
T
 
þ
Xn1
i¼1
li study
where CVRF is the vector of the reported means, b0 is the esti-
mated mean, b1 and b2 are, respectively, the associated coefﬁ-
cients of sine and cosine functions, t ¼ 1; . . . ;T is the time
period, corresponding to the monthly data, T ¼ 12 is the
number of time periods described by the sinusoidal curve to
assess yearly seasonality with one minimum value (nadir) and
one maximum value (peak) per year, and li is the associated
coefﬁcient of the indicator variable for the study i, assuming
that there are n studies. The amplitude, that is, the distance
from the mean to the peak or nadir, was estimated asﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b21 þ b22
q
; and therefore, the seasonal variation, that is, the
maximal difference between peak and nadir, was 2*amplitude.
The month of the two extreme values, nadir and peak in (0,T)
were estimated by solving t ¼ tan1 (ðb1=b2Þ=ðT=2pÞ). If
b1=b2 . 0: t indicates the month of the ﬁrst extreme (the peak
if b1 . 0, the nadir otherwise) and t+T/2 the month of the
second one (the nadir if b1 . 0, the peak otherwise). If
b1=b2  0, the month of the ﬁrst extreme is found at t+T/2,
and the month of the second one at t+T. The percentage of the
between-month variance explained by the sinusoidal curve was
estimated using the adjusted R2 measure.
A simulated effect attributable to seasonal variations in
CVRFs was modelled by calculating the 10-year risk of dying
from CV for the age range 40 years to 65 years using Stata
V.12.1 (Stata Corp, College Station, Texas, USA). Simulations
were conducted using the SCORE model for low-risk coun-
tries12 for countries in the Northern Hemisphere, and using the
recalibrated Australian SCORE equation13 for countries in the
Southern Hemisphere (see online supplementary appendix 2).
Brieﬂy, the absolute difference on 10-year risk of dying from
CV disease between the peak and the nadir months for partici-
pants aged between 40 years and 65 years was modelled by
introducing in the SCORE equation the seasonal variation of
each CVRF. Within each hemisphere, the simulations were con-
ducted taking into account gender, smoking status and age
group, and using seasonal variation of systolic blood pressure
and total cholesterol.
RESULTS
Characteristics of participants
The characteristics of the participants in the different studies are
summarised in online supplementary table S1. There were
192 129 participants in the Northern Hemisphere and 45 850
in the Southern Hemisphere. Age ranged from 18 years to
99 years, most studies presenting a mean age between 50 years
and 60 years. Women represented half or more of the partici-
pants, with the exception of BELSTRESS and the Workforce
Diabetes Survey where this percentage was considerably lower;
the PRIME Belfast study included only men. Finally, the per-
centage of current smokers varied between 15% and 70% in
men and between 8% and 58% in women.
Seasonality analyses
Seasonal analyses were carried out using data adjusted for age,
gender and current smoking (yes/no). For blood pressure, lipids
and glucose levels, further adjustment on BMI and drug treat-
ment (yes/no) was performed. Table 1 summarises the estimated
seasonal variation, nadir and peak when a seasonal pattern was
observed for a given CVRF, and adjusted R2. The graphical rep-
resentation of seasonal variations for anthropometric data, lipid
parameters and glycaemia levels is shown in online supplemen-
tary ﬁgures S1 and S2.
For anthropometric variables, BMI displayed a seasonal
pattern over time. The estimated seasonal variations were
0.26 kg/m2 and 0.52 kg/m2 for the Northern and the Southern
Hemispheres, respectively, with corresponding nadirs occurring
in July and December. For waist circumference, a seasonal vari-
ation was observed in the Northern Hemisphere only, with an
estimated variation of 0.57 cm, and the nadir occurring in July.
In the Northern Hemisphere, the sinusoidal curve explained
over 95% of the total variance for BMI and waist, while in the
Southern Hemisphere, this percentage was slightly lower, 78%
for BMI and 82% for waist.
SBP as well as DBP showed a seasonal pattern (ﬁgure 1). For
SBP, the estimated seasonal variations were approximately
2.9 mm Hg and 3.4 mm Hg in the Northern and the Southern
Hemispheres, respectively, with nadirs occurring in June and
January, respectively. For DBP, the estimated seasonal variations
were 1.4 mm Hg and 0.9 mm Hg in the Northern and the
Southern Hemispheres, respectively, the nadirs occurring in
June and November, respectively. In the Northern Hemisphere,
the sinusoidal curve explained 95% and 96% of the total vari-
ance for SBP and DBP, while in the Southern Hemisphere this
percentage was 98% for SBP and 59% for DBP.
Most lipid parameters showed a seasonal pattern. For trigly-
cerides, the estimated seasonal variations were 0.02 mmol/L and
0.07 mmol/L in the Northern and the Southern Hemispheres,
respectively, the nadirs occurring in April and July, respectively.
In the Northern Hemisphere, for total HDL and LDL choles-
terol levels, the estimated seasonal variations were 0.10 mmol/L,
0.01 mmol/L and 0.11 mmol/L, respectively, with nadirs occur-
ring in summer months. In the Southern Hemisphere, only total
cholesterol levels showed a seasonal pattern, with estimated sea-
sonal variation of 0.21 mmol/L and the nadir occurring in
October. In the Northern Hemisphere, the sinusoidal curve
explained between 91% and 93% of the total variance of lipids,
while in the Southern Hemisphere the percentages varied from
64% to 89%.
Glycaemia levels also showed a seasonal pattern. The esti-
mated seasonal variations were 0.07 mmol/L and 0.17 mmol/L
in the Northern and the Southern Hemispheres, respectively,
1518 Marti-Soler H, et al. Heart 2014;100:1517–1523. doi:10.1136/heartjnl-2014-305623
Cardiac risk factors and prevention
 o
n
 31 July 2018 by guest. Protected by copyright.
http://heart.bmj.com/
H
eart: first published as 10.1136/heartjnl-2014-305623 on 30 May 2014. Downloaded from 
the nadirs occurring in August and October, respectively. In the
Northern Hemisphere, the sinusoidal curve explained 98% of
the total variance of glycaemia, while in the Southern
Hemisphere this percentage was lower at 67%.
Sensitivity analyses
As lipids and plasma glucose vary according to fasting status, a
sensitivity analysis was performed on the 16 studies (14 in the
Northern Hemisphere and 2 in the Southern Hemisphere) that
collected blood samples in the fasting state. The results are sum-
marised in table 2. Lipid as well as glucose levels showed a sea-
sonal pattern, with estimated seasonal variation of 0.03 mmol/L
for triglycerides, 0.13 mmol/L for total cholesterol, 0.02 mmol/
L for HDL cholesterol, 0.12 mmol/L for LDL cholesterol and
0.08 mmol/L for glucose. Most nadirs occurred between June
and July, with the exception of triglycerides, where the nadir
occurred in March. Finally, the proportion of the total variance
explained by the sinusoidal curve was higher than 80% for all
markers studied. Graphical representation of seasonal variations
for lipid parameters and glycaemia levels is shown in online sup-
plementary ﬁgures S3 and S4.
Estimated impact on cardiovascular mortality
The results of the simulation of the absolute difference in
10-year risk of dying from CV disease in the peak relative to the
nadir month are summarised in ﬁgure 2. Brieﬂy, the excess risk
increased with age, smoking status and male sex. For a
65-year-old man living in the Northern Hemisphere and who
smoked, the excess 10-year risk of dying from CV disease in
winter relative to summer was as high as 6.9%, while for a non-
smoking woman aged 40 years, the excess risk was less than
0.1% (ﬁgure 2).
DISCUSSION
To our knowledge, this is the largest and most comprehensive
study ever conducted to assess the seasonality of CVRFs. Our
results strongly suggest that CVRFs present a seasonal pattern with
lower levels in summer and higher levels in winter, suggesting that
Table 1 Seasonal variation estimates of cardiovascular risk factors
Northern Hemisphere Southern Hemisphere
Seasonal variation Nadir Peak Adjusted R2 Seasonal variation Nadir Peak Adjusted R2
Body Mass Index (kg/m2)* 0.26† July January 0.97 0.52† December June 0.78
Waist circumference (cm) * 0.57† July January 0.95 0.77 0.82‡
Systolic blood pressure (mm Hg)§ 2.93† June December 0.95 3.44† January July 0.98
Diastolic blood pressure (mm Hg)§ 1.42† June December 0.96 0.86† November May 0.59
Triglycerides (mmol/L)§ 0.02† April October 0.94 0.07† July January 0.87
Total cholesterol (mmol/L)§ 0.10† June December 0.91 0.21† October April 0.85
HDL cholesterol (mmol/L)§ 0.01† August February 0.93 0.04 0.64
LDL cholesterol (mmol/L)§ 0.11† July January 0.91 0.10 0.89‡
Glycaemia (mmol/L)§ 0.07† August February 0.98 0.17† October April 0.67
Data from 21 studies from the Northern Hemisphere and 3 from the Southern Hemisphere. Results are presented as seasonal variation, nadir, peak and adjusted R2 (percentage of
variance explained).
*Adjusted for gender, age and smoking.
†Seasonal variation statistically significant at 5% level, that is, at least one of the associated p values of sine or cosine functions <0.05.
‡Data were available for two studies only.
§Adjusted for gender, age, smoking and Body Mass Index.
Figure 1 Seasonal variation in blood pressure estimated using weighted ﬁxed-effects models including cosinor function, with one peak and one
nadir for a time period of 12 months. Each study is represented as a line: dot lines and diamonds for studies in the Northern Hemisphere, and solid
lines and circles for studies in the Southern Hemisphere.
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at least part of the patterning might be due to changes in air/
outdoor temperature. Another possible explanation would be dif-
ferences in exposure to sunlight, leading to differences in vitamin
D levels and, thus, in CVRFs14; still, the effect of sunlight expos-
ure on CVRFs has been questioned.15 Other factors such as
increased levels of air pollution can also play a role. Higher con-
centrations of some pollutants have been associated with colder
periods, and the relationship between an increased level of air pol-
lution and cardiovascular disease has previously been estab-
lished.16 Changes associated with winter/cold seasons, such as
social withdrawal, the consumption of a diet with higher fat
content and decreased levels of physical activity 17 can also par-
tially contribute to the seasonal pattern. This patterning cannot be
attributed to the seasonal variation of BMI, as all analyses were
conducted using BMI-adjusted data. Indeed, CVRFs can be
mediated by BMI, as evidenced by the complete remission or con-
siderable improvement of high blood pressure, cholesterol or
glucose levels following weight loss after caloric reduction or bar-
iatric surgery.18 19 Hence, adjustment on BMI was deemed neces-
sary prior to analysing the seasonality of the other CVRFs.
This is also the ﬁrst study which includes observations from
both hemispheres. As winter in the Northern Hemisphere corre-
sponds to summer in the Southern Hemisphere, this should lead
to a mirror image of seasonal variations, which was actually
observed in the present study.
Anthropometry
BMI and waist circumference showed a small seasonal variation,
a ﬁnding already reported in the literature.6 The most likely
explanation is changes in physical activity20 or dietary intake21
during the warmer months. For instance, whereas total energy
intake does not change between winter and summer, diet com-
position does, with a higher intake of fat-rich foods in winter.22
Blood pressure
Blood pressure values were higher in winter than in summer;
this ﬁnding has been repeatedly reported.23 24 The seasonal var-
iations for SBP were approximately 2.9 mm Hg and 3.4 mm Hg
in the Northern and the Southern Hemispheres, respectively.
The most likely explanation is changes in lifestyle or in tempera-
ture. Temperature shifts lead to arteriolar vasoconstriction,
decreased sweating and increased salt load.24 25 Seasonal vari-
ation in the concentration of air pollutants might also inﬂuence
blood pressure levels through the modulation of the autonomic
nervous system, the activation of the renin-angiotensin system
and the increase in endothelin.26 The higher consumption of
vegetables and fruits in summer21 could also intervene via an
increase in potassium intake.27 Finally, the reduced synthesis of
vitamin D in winter could increase blood pressure levels, as
vitamin D has been shown to inhibit the renin-angiotension
system25; however, this hypothesis has been challenged.15
Table 2 Seasonal variation estimates of lipids and glycaemia, restricted to studies that collected fasting blood samples
Northern Hemisphere Southern Hemisphere
Seasonal variation Nadir Peak Adjusted R2 Seasonal variation Nadir Peak Adjusted R2
Triglycerides (mmol/L) 0.03* April October 0.92 0.09* July January 0.54
Total cholesterol (mmol/L) 0.13* June December 0.89 0.07 0.64
HDL cholesterol (mmol/L) 0.02* June December 0.85 0.08* June December 0.46
LDL cholesterol (mmol/L) 0.12* July January 0.92 0.22 0.08†
Glycaemia (mmol/L) 0.08* June December 0.97 0.02 0.50
Data from 14 studies from the Northern Hemisphere and 2 from the Southern Hemisphere. Data adjusted for gender, age, smoking, body mass index and hypolipidemic (for lipids) or
antidiabetic (for glycaemia) drug treatment. Results are presented as seasonal variation, nadir, peak and adjusted R2 (percentage of variance explained).
*Seasonal variation statistically significant at 5% level, that is, at least one of the associated p values of sine or cosine functions <0.05.
†Data were available for one study only.
Figure 2 Effect of seasonal variation in cardiovascular risk factors on 10-year risk of dying from cardiovascular disease. The chart shows the
absolute risk difference on 10-year risk of dying from CV disease between the peak and the nadir months for each hemisphere and for different
gender, age and smoking combinations. Simulations were performed using the SCORE equation for low-risk countries for countries in the Northern
Hemisphere, and using the recalibrated Australian SCORE equation for countries in the Southern Hemisphere.
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Interestingly, the seasonal variations observed in our study are
comparable and even slightly higher than those reported for
genetic scores for blood pressure,28 suggesting that season might
exert a similar or even greater effect on average blood pressure
levels than currently known genetic markers. Our results also
suggest that studies assessing small effects on blood pressure
(such as genome-wide association studies) should take into
account the effect of season on their analysis.
Lipids
Seasonality was observed for triglycerides, total HDL and LDL
cholesterol levels in the Northern Hemisphere. These ﬁndings
are in agreement with several studies8 27 and partly with
others29 where seasonality was found in men only. Possible
explanations include a higher intake of fat in winter22 and an
increased consumption of vegetables and fruits in summer27
although no signiﬁcant changes in dietary intake have been
reported by others.8 Seasonal variations in plasma volume (hae-
modilution in summer and haemoconcentration in winter) have
also been suggested.8
Seasonal variation of lipid levels had already been acknowl-
edged in the European guidelines for management of dyslipide-
mias 30 and could be of clinical importance in clinical trials or
epidemiological studies. For instance, in the PROVE-IT trial,
achievement of the LDL-goal was signiﬁcantly higher in summer
than in winter.31 Similarly, epidemiological studies conducted
during the cold months might report higher levels of CVRFs
than in warm months. Thus, it would be of interest that epi-
demiological studies be conducted throughout a whole year or,
alternatively, that the exact timing of the study be reported.
Glycaemia
Seasonality of glucose levels has been reported among diabetic
patients, with a peak in winter and a nadir in summer.32 A similar
pattern has been observed for glycosylated haemoglobin among
non-diabetic subjects.33 In this study, a slight seasonal variation in
glycaemia was observed, and the estimated variation was not
modiﬁed when the analysis was restricted to studies that collected
blood samples in the fasting state (see online supplementary ﬁgure
S2). Several explanations have been put forward, namely an
increase in hyperglycaemic hormones,33 partly compensated by a
parallel increase in insulin levels.9 Other possible explanations
include changes in insulin sensitivity due to decreased tempera-
tures in winter or increased physical activity in summer.33
Estimated impact on cardiovascular mortality
The seasonal variations in CVRFs led to signiﬁcant differences in
estimated 10-year risk of dying from CV disease according to
season. In elderly subjects, this difference ranged between 1.8% and
9.9%. Although the increase in CVRFs in the colder months might
not translate into a higher risk of CVD in the future at the individ-
ual level, it does have clinical and population consequences. For
instance, at the clinical level, a subject screened in the colder
months will have a higher calculated 10-year risk of CVD and, thus,
a higher likelihood of receiving preventive advice or treatment than
in the warmer months. At the population level, the higher risk of
future CVD event in colder months could also translate into a
higher immediate risk: higher BP levels in the colder months could
promote the triggering of CVD, such as stroke or myocardial
infarction. Although the calculations were performed mainly for
illustrative purposes, they suggest that the seasonal variation of
CVRFs could partly explain the seasonality of CVD deaths in most
countries.34 35 Nevertheless, further studies are needed to better
assess this point.
Strengths and weaknesses
To our knowledge, this is the largest and most comprehensive
study ever conducted to assess the seasonality of CVRFs. Our
results replicate between studies, and also between the Northern
and the Southern Hemispheres.
This study has also some weaknesses worth acknowledging.
First, only data from two countries of the Southern Hemisphere
(Australia and New Zealand) were available. This led to smaller
sample sizes, which might have prevented the assessment of sea-
sonal patterns for some CVRFs in the Southern Hemisphere.
Indeed, the percentage of the between-month variability
explained by the sinusoidal curve was generally lower in the
Southern Hemisphere than in the Northern Hemisphere.
Nevertheless, only for DBP, HDL cholesterol and glycaemia, the
percentage of variance explained by cosinor curve was lower
than 70%. Second, the use of the cosinor model might be ques-
tionable, and a mixed-effects model might have been appropri-
ate. However, preliminary results showed a similar seasonal
pattern in most within-study analyses. Thus, no clear heterogen-
eity was found between studies, that is, studies with high values
of CVRFs did not present a stronger seasonal pattern than
studies with lower values. Further, the cosinor model can be
described as a linear regression model using sine and cosine
functions,36 which has several advantages: it allows us to cor-
rectly estimate seasonal variations, and it is more ﬂexible than
polynomial regression, such as quadratic or cubic polynomials.
Still, in the context of linear regression, the cosinor model pro-
vides a straightforward estimation of the seasonal variation,
nadir and peak, as well as a measure of the goodness-of-ﬁt.
Third, the SCORE equation for low-risk countries was used,
and it is likely that using the high-risk equation would have led
to bigger seasonal risk differences. Hence, our estimations can
be considered as conservative. Finally, seasonality was assessed
using one single measurement from each study participant,
instead of multiple measurements performed over time in the
Key messages
What is known on this subject?
Cardiovascular events have been shown to present a seasonal
pattern, their rates being higher in winter than in other seasons.
Seasonal patterns for cardiovascular risk factors (CVRFs) have
also been suggested for Body Mass Index (BMI), waist
circumference, blood pressure, lipids and glycaemia.
However, most studies assessing the seasonality of CVRFs have
been conducted in relatively small studies or focused on a single
CVRF.
What might this study add?
A seasonal pattern characterised by higher levels in winter and
lower levels in summer of CVRF levels was demonstrated in 24
populations of both hemispheres using a common methodology.
The magnitude of the seasonal effect is comparable to the
pooled effect of genetic markers.
The seasonal pattern of CVRFs could explain the seasonality of
CV mortality.
How might this impact on clinical practice?
Interpretation of individual risk factors levels might be different
depending on season: a low value in winter is deﬁnitely a low
‘yearly’ value, but a low value in summer does not mean a low
value in winter.
Marti-Soler H, et al. Heart 2014;100:1517–1523. doi:10.1136/heartjnl-2014-305623 1521
Cardiac risk factors and prevention
 o
n
 31 July 2018 by guest. Protected by copyright.
http://heart.bmj.com/
H
eart: first published as 10.1136/heartjnl-2014-305623 on 30 May 2014. Downloaded from 
same persons. However, the results were adjusted for the main
confounders and it is unlikely that the same recruiting bias (ie,
subjects with low levels of CVRFs being recruited only in
summer) would appear in most studies.
CONCLUSION
Cardiovascular risk factors show a seasonal pattern characterised
by higher levels in winter and lower levels in summer. This
pattern could contribute to the seasonality of CV mortality.
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